(CLOSED) 2019/2020 Tobacco CURE Nonformula Opioid Abuse

Sponsor Name: 
PA DOH
Amount: 
$4,000,000.00
Description of the Award: 

The intent of the state’s Request for Applications (RFA) is to fund Collaborative Research on Opioid Abuse and the Overdose Crisis. An application must include plans for conducting only one research project that shall be focused on opioid abuse and the overdose crisis. The collaborative research project must involve an applicant and one or more collaborating organizations that cooperate to identify priorities and conduct research. The collaborative research project must provide for the sharing of infrastructure, resources and expertise. The applicant and collaborating organizations must be separate institutions. The application must describe the roles of the applicant and the collaborating organizations and demonstrate that the collaborating partners will be playing real and substantive roles in the research project. The research project must have one common goal, with the collaborating organizations working together on all phases of the project instead of each collaborating organization working independently on separate phases of the research project.

Only the following types of research, may be conducted:

  1. Biomedical research - comprehensive research pertaining to the application of the natural sciences to the study and clinical practice of medicine at an institution, including biobehavioral research related to tobacco use.
  2. Clinical research- patient-oriented research which involves direct interaction and study of the mechanisms of human disease, including therapeutic interventions, clinical trials, epidemiological and behavioral studies and the development of new technology.
  3. Health services research - includes any of the following: (1) research on the promotion and maintenance ofhealth including biobehavioral research, (2) research on the prevention and reduction of disease, (3) research on the delivery of health care services to reduce health risks and transfer research advances to community use.

The primary goal of this RFA is to fund collaborative research on opioid abuse and the overdose crisis. The collaborative research project funded by this RFA will bring together established research scientists with proven records of scientific excellence to work with clinicians, non-traditional partners and other researchers, including junior faculty as members of the research team. Collaboration among and between universities or academic medical centers, in association with businesses, health care providers, public agencies, smaller colleges and universities and other institutions or organizations that are not academic medical centers is encouraged. The collaborating organizations will share essential facilities, services, knowledge, and other resources to conduct research designed to improve the health of Pennsylvanians.

In recent years, there have been enormous advances in research facilities. The RFA provides support for research infrastructure to keep Pennsylvania research institutions in the forefront of these advances. It also will afford the opportunity for the training of researchers and undergraduate, graduate and postgraduate students through participation in the research project.

The specific objectives are:

  1. To assist in the elimination or reduction of disparities in health status, outcome, prevention or treatment.
  2. To promote competitive research development and technology transfer in health sciences that are important to Pennsylvania.
  3. To foster interdisciplinary research by teams of scientists and others.
  4. To promote collaborative efforts among academic, business, advocacy and public health institutions.
  5. To provide a catalyst for funding from philanthropic, Federal and other non-state government sources.
  6. To provide flexibility in order to foster atypical teams who may not usually seek to affiliate for research.

State-level Competition Details:

Questions regarding the RFA must be directed in writing to the Manager, Health Research Program, through email at ra-healthresearch@pa.gov no later than 2:30 p.m. on July 31, 2018.

A pre-application conference will be held on August 7, 2018 at 8:00 a.m. in conference room 129, Health and Welfare Building, 625 Forster Street, Harrisburg, PA 17120-0701. Penn State can have two individuals attend.

hard copy of the letter of intent (REQUIRED) is due to the state no later than 2:30 pm on August 14.

The final application (which cannot be submitted electronically) is due August 22 no later than 2:30 pm.

Limit (Number of applicants permitted per institution): 
1
Sponsor LOI Deadline: 
Aug 14, 2018
Sponsor Final Deadline: 
Aug 22, 2018
OSVPR Application or NOI Instructions: 

Interested applicants should download the Letter of Intent document attached to this competition in InfoReady, fill out and upload in a PDF file (File name: Last name_LOITobacco_2018) no later than 5:00 p.m. on Wednesday, July 25, 2018.

We will inform the applicants of the results of the internal competition by July 31.

Please contact the limited submission Office (limitedsubs@psu.edu) or John Anthony (jta11@psu.edu; 814-935-1081), Tobacco CURE Manager, if you have any questions.

To be considered as a Penn State institutional nominee, please submit a notice of intent by the date provided directly below.
Penn State OSVPR NOI Deadline: 
Wednesday, July 25, 2018 - 5:00pm
This limited submission is in downselect: 
Penn State may only submit a specific number of proposals to this funding opportunity. The number of NOIs received require that an internal competition take place, thus, a downselect process has commenced. No Penn State researchers may apply to this opportunity outside of this downselect process. To apply for this limited submission, please use this link:
OSVPR Downselect Deadline: 
Wednesday, July 25, 2018 - 5:00pm
Notes: 
Grigson, Patricia (College of Medicine, Neural & Behavioral Sciences) 7/31/2018